Tirzepatide may take it a step further, leveraging combined GIP and GLP-1 actions to curb appetite, boost energy expenditure, and drive greater weight loss
Louisiana Illuminator is part of States Newsroom, a nonprofit news network supported by grants and a coalition of donors as a 501c(3) public charity
In the SURPASS-2 head-to-head against semaglutide for diabetes, tirzepatide produced significantly greater A1c reductions
But if you have received the same prescription from the same pharmacy multiple times and this vial is dramatically darker than previous ones, that inconsistency deserves a phone call
Side effects above come from the current FDA prescribing information on DailyMed, accessed May 27, 2026: Foundayo (orforglipron), revised April 2026, and Wegovy (semaglutide injection and tablets), revised May 2026